Robert S Mannel

Robert S Mannel

UNVERIFIED PROFILE

Are you Robert S Mannel?   Register this Author

Register author
Robert S Mannel

Robert S Mannel

Publications by authors named "Robert S Mannel"

Are you Robert S Mannel?   Register this Author

92Publications

2516Reads

20Profile Views

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.

N Engl J Med 2019 11;381(20):1929-1939

From the University of Texas M.D. Anderson Cancer Center, Houston (R.L.C., K.B.-E.); Women's Cancer Center of Nevada, Las Vegas (N.M.S.); NRG Oncology Statistical and Data Management Center, Roswell Park Cancer Institute, Buffalo (D.E., H.Q.H., M.F.B.), and Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (P.S.) - both in New York; the University of Cincinnati, University of Cincinnati Cancer Institute, Cincinnati (T.J.H.); the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore (D.K.A.); Seoul National University College of Medicine (J.-W.K.), Samsung Medical Center, Sungkyunkwan University School of Medicine (B.-G.K.), and Asan Medical Center, University of Ulsan College of Medicine (J.-H.N.), Seoul, and the Research Institute and Hospital, National Cancer Center, Goyang (S.-Y.P.) - all in South Korea; Saitama Medical University International Medical Center, Hidaka, Japan (K.F.); the University of Oklahoma Health Sciences Center, Oklahoma City (J.L.W., R.S.M.); National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, U.S. Oncology Research, and Metro-Minnesota Community Oncology Research Consortium, Minneapolis (A.C.C.); Duke Cancer Institute, Duke University Medical Center, Durham, NC (A.A.S.); Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.R.); Gynecologic Cancer Program, California Pacific-Palo Alto Medical Foundation, Sutter Research Institute, San Francisco (J.K.C.); Women and Infants Hospital, Providence, RI (P.D.); the University of Colorado School of Medicine, Aurora, and Denver Health Medical Center, Denver (S.A.D.); Ohio State University, Columbus (D.E.C.); and the University of California, Irvine, Orange (K.S.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1902626DOI Listing
November 2019

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.

Gynecol Oncol 2019 08 19;154(2):420-425. Epub 2019 Jun 19.

Department of Obstetrics and Gynecology, Peggy and Charles Stephenson Cancer Center - University of Oklahoma, Oklahoma City, OK 73104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.05.013DOI Listing
August 2019

Prediction of chemotherapy response in ovarian cancer patients using a new clustered quantitative image marker.

Phys Med Biol 2018 08 6;63(15):155020. Epub 2018 Aug 6.

School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK 73019, United States of America. These authors contributed equally to this work.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/aad3abDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286643PMC
August 2018

Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.

Radiology 2018 04 29;287(1):176-184. Epub 2017 Nov 29.

From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Ellison 237, Boston, Mass 02114 (M.S.G., S.I.L.); Department of Medical Imaging, University of Toronto, Toronto, Canada (M.A.); Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pa (A.I.B.); Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, Okla (R.S.M.); and Department of Obstetrics and Gynecology, Tulsa Cancer Institute, Tulsa, Okla (M.A.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017170963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881639PMC
April 2018

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.

Br J Cancer 2018 01 28;118(2):162-170. Epub 2017 Nov 28.

Department of Pathology (SL) and Department of Gynecologic Oncology (KT), Irvine Medical Center, University of California, Orange, CA 92868, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785748PMC
January 2018

Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.

J Natl Cancer Inst 2017 11;109(11)

Genentech Inc., South San Francisco, CA; F Hoffmann-La Roche Ltd, Basel, Switzerland; NRG Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY; University of Oklahoma, Oklahoma City, OK; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA; Center for Cancer Research, Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; HistoGeneX NV, Antwerp, Belgium; Division of Physiopharmacology, University of Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440032PMC
November 2017

Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy.

Acad Radiol 2017 10 26;24(10):1233-1239. Epub 2017 May 26.

School of Electrical and Computer Engineering, University of Oklahoma, 101 David L. Boren Blvd, Norman, OK 73019. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2017.04.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875685PMC
October 2017

Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.

Radiology 2017 05 3;283(2):450-459. Epub 2017 Jan 3.

From the Department of Medical Imaging, NCSB 1C569 Toronto General Hospital, University of Toronto, University Health Network, 585 University Ave, Toronto, ON, Canada M5G 2N2 (M.A.); Center for Statistical Sciences, Brown University, Providence, RI (F.D., H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (F.D.); Department of Radiology, Massachusetts General Hospital, Boston, Mass (S.I.L.); Roswell Park Cancer Institute, Buffalo, NY (S.A.); Department of Radiation Oncology, University of Washington Medical Center, Seattle, Wash (W.J.K.); University of Oklahoma Health Sciences Center, Oklahoma City, Okla (R.S.M., K.M.M.); Department of Gynecologic Oncology, Women and Infants Hospital, Providence, RI (P.D.); Seattle Cancer Care Alliance, Seattle, Wash (S.A.K.); School of Medicine, Stony Brook University Health Sciences Center, Stony Brook, NY (M.P.); Department of Gynecologic Oncology, University of Connecticut School of Medicine Hartford HealthCare Cancer Institute at the Hospital of Central Connecticut, New Britain, Conn (X.C.Z.); Department of Obstetrics and Gynecology, Laval University, Quebec City, Quebec, Canada (M.P.); and Department of Gynecologic Oncology, Tulsa Cancer Institute, Tulsa, Okla (M.G.).

View Article

Download full-text PDF

Source
http://pubs.rsna.org/doi/10.1148/radiol.2016160200
Publisher Site
http://dx.doi.org/10.1148/radiol.2016160200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410939PMC
May 2017

FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

Gynecol Oncol 2017 05 15;145(2):366-373. Epub 2017 Mar 15.

Queensland University of Technology (QUT) at the Translational Research Institute, Brisbane, Australia; Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.02.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433848PMC
May 2017

Effectiveness of cyanoacrylate microbial sealant in the reduction of surgical site infection in gynecologic oncology procedures: A phase III single institution prospective randomized trial.

Gynecol Oncol 2017 Jan 9;144(1):193-199. Epub 2016 Nov 9.

Stephenson Oklahoma Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Oklahoma, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.11.008DOI Listing
January 2017

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.

Obstet Gynecol 2016 Sep;128(3):535-42

Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; the NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York; Spectrum Health Medical Group, Grand Rapids, Michigan; the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; the University of Colorado Cancer Center, Aurora, Colorado; New Britain General Hospital, Plainville, Connecticut; Women's Cancer Center, Las Vegas, Nevada; UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California; Royal Hallamshire Hospital, Sheffield, United Kingdom; and the University of Texas Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/greenjournal/2016/09000/Second_
Web Search
http://dx.doi.org/10.1097/AOG.0000000000001554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993663PMC
September 2016

Initiation of a formalized precision medicine program in gynecologic oncology.

Gynecol Oncol 2016 Apr;141(1):24-8

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, 800 NE 10th Street, Oklahoma City, OK 73104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.02.024DOI Listing
April 2016

Is the NCI MATCH trial a match for gynecologic oncology?

Gynecol Oncol 2016 Jan 14;140(1):161-6. Epub 2015 Nov 14.

Stephenson Oklahoma Cancer Center at the University of Oklahoma, Oklahoma City, OK, United States.

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S009082581530175X/1-s2.0-S009082581530
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S009082581530175
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2015.11.003DOI Listing
January 2016

Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study.

J Clin Oncol 2015 Apr 23;33(10):1180-5. Epub 2015 Feb 23.

Martee L. Hensley, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York; Austin Miller, NRG Oncology, Buffalo, NY; David M. O'Malley, The Ohio State University, Columbus, OH; Robert S. Mannel, University of Oklahoma, Oklahoma City, OK; Kian Behbakht, University of Colorado Denver, Aurora, CO; Jamie N. Bakkum-Gamez, Mayo Clinic, Rochester, MN; and Helen Michael, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.3781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372854PMC
April 2015

Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Int J Gynecol Pathol 2014 Nov;33(6):543-53

Division of Anatomic Pathology (R.J.Z., W.T.), Hershey Medical Center, Pennsylvania State University, Hershey, Pennysylvania Gynecologic Oncology Group Statistical and Data Center (W.E.B.), Buffalo, New York University of Iowa Med Center (K.L., M.I.), Iowa City, Iowa University of New Mexico (E.G.F.), Albuquerque, New Mexico Dana-Farber Partners Cancer Care Center, Brigham and Women's Hospital (an Affiliate of Fox Chase Cancer Center) (N.S.H.) Massachusetts General Hospital (L.R.D.), Dana-Farber Partners Cancer Care Center, (an Affiliate of Fox Chase Cancer Center), Boston, Massachusetts University of Oklahoma (R.S.M., J.L.W.), Oklahoma City, Oklahoma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533989PMC
November 2014

Anti-angiogenic therapy versus dose-dense paclitaxel therapy for frontline treatment of epithelial ovarian cancer: review of phase III randomized clinical trials.

Curr Oncol Rep 2014 Nov;16(11):412

Department of Obstetrics and Gynecology, Oklahoma University Health Sciences Center, 800 N.E. 10th Street, Oklahoma, OK, 73103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-014-0412-2DOI Listing
November 2014

SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm.

Gynecol Oncol 2014 Oct 12;135(1):3-7. Epub 2014 Aug 12.

The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698962PMC
October 2014

Pemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group.

J Clin Oncol 2014 Sep 28;32(25):2744-9. Epub 2014 Jul 28.

David Scott Miller, University of Texas Southwestern Medical Center, Dallas; Lois M. Ramondetta and Jubilee Brown, MD Anderson Cancer Center, Houston, TX; John A. Blessing, Roswell Park Cancer Institute, Buffalo, NY; Huyen Q. Pham, University of Southern California, Los Angeles; Krishnansu S. Tewari, University of California Medical Center at Irvine, Orange, CA; and Lisa M. Landrum and Robert S. Mannel, University of Oklahoma, Oklahoma City, OK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.7448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145184PMC
September 2014

Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors.

Gynecol Oncol 2014 Jan 9;132(1):50-4. Epub 2013 Nov 9.

Section of Gynecology Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.11.005DOI Listing
January 2014

Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.

Gynecol Oncol 2013 Mar 4;128(3):573-8. Epub 2012 Dec 4.

Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Department of Obstetrics and Gynecologic Oncology, 500 W. Thomas Road, Suite 600, Phoenix, AZ 85013, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.11.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099057PMC
March 2013

A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study.

Gynecol Oncol 2012 Dec 7;127(3):456-61. Epub 2012 Sep 7.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Oklahoma, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.08.030DOI Listing
December 2012

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer.

Gynecol Oncol 2011 Sep 12;122(3):527-31. Epub 2011 Jun 12.

University of Oklahoma Health Sciences Center, Section of Gynecology Oncology, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.05.022DOI Listing
September 2011

Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.

J Clin Oncol 2010 Jun 26;28(16):2727-31. Epub 2010 Apr 26.

Washington University School of Medicine, Department of Obstetrics/Gynecology, 4911 Barnes-Jewish Hospital Plaza, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.8326DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881851PMC
June 2010

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.

Gynecol Oncol 2009 Nov 26;115(2):215-20. Epub 2009 Aug 26.

The Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.07.023DOI Listing
November 2009

Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.

J Clin Oncol 2009 Jun 30;27(16):2686-91. Epub 2009 Mar 30.

University of Texas Southwestern Medical Center at Dallas, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Dallas, TX 75390-9032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.2963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690393PMC
June 2009

Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.

Gynecol Oncol 2009 Mar 9;112(3):553-7. Epub 2009 Jan 9.

The Ohio State University, Gynecologic Oncology, M210 Starling-Loving Hall, 320 West Tenth Avenue, Columbus, OH 43210-1228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.11.026DOI Listing
March 2009

A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group.

Gynecol Oncol 2008 Oct;111(1):22-6

Division of Medical Oncology, University of Southern California, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.06.013DOI Listing
October 2008

Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

Gynecol Oncol 2008 Aug 20;110(2):133-9. Epub 2008 May 20.

University of Oklahoma Health Sciences Center, Division of Gynecologic Oncology, Oklahoma City, Oklahoma 73103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.03.008DOI Listing
August 2008

Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.

Gynecol Oncol 2007 Aug 9;106(2):362-9. Epub 2007 May 9.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mercer University School of Medicine, 840 Pine Street, Suite 760, Macon, GA 31201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.04.007DOI Listing
August 2007

Staffing for hospital lactation programs: recommendations from a tertiary care teaching hospital.

J Hum Lact 2006 Nov;22(4):409-17

OU Medical Center, Oklahoma City, Oklahoma, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0890334406294166DOI Listing
November 2006

Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone.

Gynecol Oncol 2006 Feb;100(2):379-84

Department of Obstetrics and Gynecology, University of Tennessee at Memphis, 854 Jefferson Ave., Room E-102, Memphis, TN 38163, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.09.015DOI Listing
February 2006

Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.

J Clin Oncol 2006 Feb;24(4):587-92

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.02.8464
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.02.8464DOI Listing
February 2006

Carcinosarcoma of the ovary-a case series.

Gynecol Oncol 2006 Jan 5;100(1):128-32. Epub 2005 Oct 5.

University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.07.119DOI Listing
January 2006

Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.

J Clin Oncol 2006 Jan 5;24(1):36-44. Epub 2005 Dec 5.

Leo W. Jenkins Cancer Center, Brody School of Medicine at East Carolina University, Greenville, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.00.7617DOI Listing
January 2006

Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study.

Gynecol Oncol 2005 Mar;96(3):810-7

Breast Cancer Program, Cedars Sinai Medical Center, Women's Cancer Research Institute, 8700 Beverly Boulevard Room 290 W, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.11.037DOI Listing
March 2005

Gynecologic oncologists' perceptions of fellowship training.

J Reprod Med 2005 Jan;50(1):29-34

Carilion Gyn Oncology Associates, Roanoke, Virginia, USA.

View Article

Download full-text PDF

Source
January 2005

Outpatient implantation of a central venous access system in gynecologic oncology patients.

J Reprod Med 2003 Nov;48(11):875-81

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

View Article

Download full-text PDF

Source
November 2003

Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Gynecol Oncol 2003 May;89(2):267-70

Division of Gynecologic Oncology, Case Western Reserve University, University Hospitals of Cleveland, OH 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0090-8258(03)00079-9DOI Listing
May 2003

Impact of individual physicians on enrollment of patients into clinical trials.

Am J Clin Oncol 2003 Apr;26(2):171-3

Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000421-200304000-00014DOI Listing
April 2003

Ascites as a predictor of ovarian malignancy.

Gynecol Oncol 2002 Oct;87(1):77-83

Gynecologic Surgery and Oncology, 2911 N. Tenaya Way, Suite 105, Las Vegas, NV 89128, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/gyno.2002.6800DOI Listing
October 2002

Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.

J Clin Oncol 2002 Apr;20(7):1832-7

Division of Gynecologic Oncology, Ellis Fischel Cancer Center, University of Missouri Health Sciences Center, Columbia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.07.045DOI Listing
April 2002

Laparoscopic pelvic and paraaortic lymph node dissection in the obese.

Gynecol Oncol 2002 Mar;84(3):426-30

Division of Gynecologic Oncology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/gyno.2001.6548DOI Listing
March 2002

Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.

Int J Radiat Oncol Biol Phys 2002 Jan;52(1):14-22

Radiation Oncology Center, Department of Radiology, Oklahoma University Health Sciences Center, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(01)01808-9DOI Listing
January 2002